Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.

Brandman D, Pingitore A, Lai JC, Roberts JP, Ferrell L, Bass NM, Terrault NA.

Liver Transpl. 2011 Dec;17(12):1380-6. doi: 10.1002/lt.22389.

2.
3.

Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis.

Li DW, Lu TF, Hua XW, Dai HJ, Cui XL, Zhang JJ, Xia Q.

World J Gastroenterol. 2015 May 28;21(20):6329-40. doi: 10.3748/wjg.v21.i20.6329. Review.

4.

Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.

Vespasiani-Gentilucci U, Gallo P, De Vincentis A, Galati G, Picardi A.

World J Gastroenterol. 2014 Mar 21;20(11):2825-38. doi: 10.3748/wjg.v20.i11.2825. Review.

5.

From prolonging life to prolonging working life: Tackling unemployment among liver-transplant recipients.

Ã…berg F.

World J Gastroenterol. 2016 Apr 14;22(14):3701-11. doi: 10.3748/wjg.v22.i14.3701. Review.

Supplemental Content

Support Center